Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility.

MLA

Cai, Bin, et al. “Mendelian Randomization Analysis and Validation Supports MEGF9 and MLLT11 as Potential Targets for the Treatment of Varicocele and Male Infertility.” Frontiers in Endocrinology, vol. 15, Sept. 2024, p. 1416384. EBSCOhost, https://doi.org/10.3389/fendo.2024.1416384.

APA

Cai, B., Sun, D., Deng, W., Jin, Y., Zhao, H., Xing, D., Liu, Y., & Jin, B. (2024). Mendelian randomization analysis and validation supports MEGF9 and MLLT11 as potential targets for the treatment of varicocele and male infertility. Frontiers in Endocrinology, 15, 1416384. https://doi.org/10.3389/fendo.2024.1416384

Chicago

Cai, Bin, Dalin Sun, Weimin Deng, Yihan Jin, Hongle Zhao, Dong Xing, Yuanyuan Liu, and Baofang Jin. 2024. “Mendelian Randomization Analysis and Validation Supports MEGF9 and MLLT11 as Potential Targets for the Treatment of Varicocele and Male Infertility.” Frontiers in Endocrinology 15 (September): 1416384. doi:10.3389/fendo.2024.1416384.